healthcare

healthcare Articles

The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most...
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Zynerba Pharma has just announced that the U.S. Patent and Trademark Office has issued a patent for the firm’s treatment of autism spectrum disorder with cannabidiol.
CymaBay Therapeutics shares were nearly halved early Tuesday after the company provided an update from its midstage study of seladelpar for the treatment of nonalcoholic steatohepatitis.
The Church of England has lifted its ban on investing in companies that sell medical marijuana.
NovaBay shares absolutely exploded on Monday after the company announced that its eye care treatment would be readily available on Amazon.
Tilray shares jumped on Monday after the firm announced that it had signed a letter of intent with its largest stockholder Privateer Holdings.
ReWalkshares took a step back on Monday after the firm announced that it would be pricing a registered direct offering for $5 million. This comes after the stock had a phenomenal week when the FDA...
New research shows that the marijuana industry will create hundreds of thousands of jobs in the United States over the next two or three years.
24/7 Wall St. has taken a look at Wedbush’s recent ASCO roundup, and we’ve picked out a few of the companies with the biggest upside potential going forward.
Cronos shares popped on Wednesday after Merrill Lynch released a very positive report. This is not something that happens every day, but the brokerage firm issued a double upgrade with very...
InflaRx shares were destroyed on Wednesday after the firm announced results from its midstage trial in patients suffering from moderate to severe hidradenitis suppurativa.
ReWalk Robotics shares absolutely exploded on Wednesday on news that the FDA has cleared the firm's ReStore soft exo-suit system for sale to rehabilitation centers across the United States.
Here is why Genocea Biosciences is one of the big winners from the annual meeting of the American Society of Clinical Oncology (ASCO).